Nageshwar Budha
- Molecular Biology
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Pharmacology top 2%
- Surgery
- Co-authors
- Mark J. DresserBernd MeibohmLeslie Z. BenetAdam FrymoyerScott N. HoldenJin Y. JinJ. A. WareRichard Lee
- Topics
- Cancer Immunotherapy and Biomarkers (12 papers)CAR-T cell therapy research (9 papers)Pharmacogenetics and Drug Metabolism (7 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Nageshwar Budha
51 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 111
- Molecular Biology 478
- Oncology 477
- Pulmonary and Respiratory Medicine 247
- Pharmacology 189
- Surgery 167
Countries citing papers authored by Nageshwar Budha
This map shows the geographic impact of Nageshwar Budha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nageshwar Budha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nageshwar Budha more than expected).
Fields of papers citing papers by Nageshwar Budha
This network shows the impact of papers produced by Nageshwar Budha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nageshwar Budha. The network helps show where Nageshwar Budha may publish in the future.
Co-authorship network of co-authors of Nageshwar Budha
This figure shows the co-authorship network connecting the top 25 collaborators of Nageshwar Budha. A scholar is included among the top collaborators of Nageshwar Budha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nageshwar Budha. Nageshwar Budha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 3 | |
| 5 | 10 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 44 | |
| 10 | 31 | |
| 11 | 15 | |
| 12 | 22 | |
| 13 | 8 | |
| 14 | Abstract 12009: Effect of RG7652, a mAb Against PCSK9, on Apolipoprotein B, Oxidized LDL, Lipoprotein(a) and Lipoprotein-Associated Phospholipase A2 in Healthy Individuals With Elevated LDL-c | 2 |
| 15 | 13 | |
| 16 | 8 | |
| 17 | 28 | |
| 18 | 29 | |
| 19 | 34 | |
| 20 | 84 |
About Nageshwar Budha
Nageshwar Budha is a scholar working on Oncology, Pharmacology and Immunology, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), CAR-T cell therapy research (9 papers) and Pharmacogenetics and Drug Metabolism (7 papers). The work is most often cited by research in Pharmacology (189 citations), Oncology (477 citations) and Pharmaceutical Science (97 citations). Nageshwar Budha has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Mark J. Dresser, Bernd Meibohm, Leslie Z. Benet, Adam Frymoyer, Scott N. Holden, Jin Y. Jin, J. A. Ware, Richard Lee, Nitin Mehrotra and Srikumar Sahasranaman. Their work appears in journals such as Circulation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.